No Data
No Data
Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of Circular RNA
Altamira Therapeutics Announces Transition From NASDAQ to OTC Markets
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Altamira Therapeutics Receives Letter From Nasdaq Qualifications Department That It Is No Longer In Compliance
Express News | Altamira Therapeutics: Got on Sept 30, a Letter From Nasdaq That It No Longer Complied With Rule 5550(a)(2) of Nasdaq's Listing Rules
Altamira Therapeutics Announces Extended ISO 13485 Quality Management System Certification for Bentrio Nasal Spray